A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients
<p>Abstract</p> <p>Background</p> <p><it>BCR-ABL </it>kinase domain (KD) mutation is the major mechanism contributing to suboptimal response to tyrosine kinase inhibitors (TKI) in <it>BCR-ABL</it>-positive chronic myeloid leukemia (CML) patients....
Main Authors: | Auewarakul Chirayu U, Thongnoppakhun Wanna, Wongboonma Wanwisa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/4/1/7 |
Similar Items
-
Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
by: Chotirat Sadudee, et al.
Published: (2012-03-01) -
T315I-mutated myeloid sarcoma
by: Yumeng Zhang, et al.
Published: (2019-01-01) -
Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M, et al.
Published: (2019) -
Mutational analysis of T315I in patients with chronic myeloid leukemia who did not respond to second-generation tyrosine kinase inhibitors
by: Riyam Qusay Ibrahim Al-Jadir, et al.
Published: (2020-01-01) -
Sensitive allele specific oligonucleotide-polymerase chain reaction in detection of preexisting mutations in imatinib-resistant chronic myelogenous leukemia patients: A retrospective analysis
by: Mukul Arvind Gharote, et al.
Published: (2015-01-01)